Clinical Trial Update: Micardis® in Patients With Essential Hypertension

View source ↗

Summary

An update on a completed clinical trial of Micardis (telmisartan) for essential hypertension. The trial was sponsored by Boehringer Ingelheim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED